Chinese Journal of Stroke ›› 2020, Vol. 15 ›› Issue (12): 1352-1359.DOI: 10.3969/j.issn.1673-5765.2020.12.016
Previous Articles Next Articles
Received:
2019-12-11
Online:
2020-12-20
Published:
2020-12-20
黄丽红,刘光维
通讯作者:
刘光维 18523438560@163.com
基金资助:
重庆医科大学附属第一医院2019年度护理科研基金(HLJJ2019-01)
HUANG Li-Hong, LIU Guang-Wei. A Review on Risk Factors Associated with Poor Prognosis after Intravenous Thrombolysis in Ischemic Stroke Patients[J]. Chinese Journal of Stroke, 2020, 15(12): 1352-1359.
黄丽红,刘光维. 缺血性卒中患者静脉溶栓后不良预后危险因素的研究现状[J]. 中国卒中杂志, 2020, 15(12): 1352-1359.
[1] POWERS W J,RABINSTEIN A A,ACKERSONT,et al. 2018 guidelines for the early management ofpatients with acute ischemic stroke:a guideline forhealthcare professionals from the American HeartAssociation/American Stroke Association[J/OL].Stroke,2018,49(3):e46-e110[2019-12-11].https://doi.org/10.1161/STR.0000000000000158.[2] 中国老年医学学会急诊医学分会,中华医学会急诊医学分会卒中学组,中国卒中学会急救医学分会. 急性缺血性脑卒中急诊急救中国专家共识2018[J]. 中国卒中杂志,2018,13(9):956-967.[3] 王陇德,刘建民,杨弋,等. 我国脑卒中防治仍面临巨大挑战——《中国脑卒中防治报告2018》概要[J].中国循环杂志,2019,34(2):105-119.[4] EMBERSON J,LEES K R,LYDEN P,et al. Effectof treatment delay,age,and stroke severity on theeffects of intravenous thrombolysis with alteplase foracute ischaemic stroke:a meta-analysis of individualpatient data from randomised trials[J]. Lancet,2014,384(9958):1929-1935.[5] ALI M,FULTON R,QUINN T,et al. How well dostandard stroke outcome measures reflect quality oflife? A retrospective analysis of clinical trial data[J].Stroke,2013,44(11):3161-3165.[6] 国家卫生计生委办公厅,国家中医药管理局办公室.国家卫生计生委办公厅国家中医药管理局办公室关于印发脑卒中综合防治工作方案的通知[R/OL].(2016-12-09)[2019-12-11]. http://www.nhc.gov.cn/jkj/s5879/201612/cef09e0c26744df38fa710d3c0da75ce.shtml.[7] KIDWELL C S,SAVER J L,CARNEADO J,et al.Predictors of hemorrhagic transformation in patientsreceiving intra-arterial thrombolysis[J]. Stroke,2002,33(3):717-724.[8] KHATRI P,KLEINDORFER D O,DEVLIN T,et al. Effect of Alteplase vs aspirin on functionaloutcome for patients with acute ischemic stroke andminor nondisabling neurologic deficits:the PRISMSrandomized clinical trial[J]. JAMA,2018,320(2):156-166.[9] WHITELEY W N,EMBERSON J,LEES K R,etal. Risk of intracerebral haemorrhage with alteplaseafter acute ischaemic stroke:a secondary analysis ofan individual patient data meta-analysis[J]. LancetNeurol,2016,15(9):925-933.[10] LEES K R,BLUHMKI E,VON KUMMER R,etal. Time to treatment with intravenous alteplaseand outcome in stroke:an updated pooled analysisof ECASS,ATLANTIS,NINDS,and EPITHETtrials[J]. Lancet,2010,375(9727):1695-1703.[11] KHATRI P,ABRUZZO T,YEATTS S D,et al.Good clinical outcome after ischemic stroke withsuccessful revascularization is time-dependent[J].Neurology,2009,73(13):1066-1072.[12] MA H,CAMPBELL B C V,PARSONS M W,etal. Thrombolysis guided by perfusion imaging up to9 hours after onset of stroke[J]. N Engl J Med,2019,380(19):1795-1803.[13] PANTONI L,FIERINI F,POGGESI A.Thrombolysis in acute stroke patients with cerebralsmall vessel disease[J]. Cerebrovasc Dis,2014,37(1):5-13.[14] KONGBUNKIAT K,WILSON D,KASEMSAPN,et al. Leukoaraiosis,intracerebral hemorrhage,and functional outcome after acute strokethrombolysis[J]. Neurology,2017,88(7):638-645.[15] IST-3 collaborative group. Association betweenbrain imaging signs,early and late outcomes,andresponse to intravenous alteplase after acuteischaemic stroke in the third International StrokeTrial(IST-3):secondary analysis of a randomisedcontrolled trial[J]. Lancet Neurol,2015,14(5):485-496.[16] CHARIDIMOU A,SHOAMANESH A. Clinicalrelevance of microbleeds in acute stroke thrombolysis:comprehensive meta-analysis[J]. Neurology,2016,87(15):1534-1541.[17] LIU X Y,LI T,DIAO S S,et al. The globalburden of cerebral small vessel disease related toneurological deficit severity and clinical outcomesof acute ischemic stroke after IV rt-PA treatment[J].Neurol Sci,2019,40(6):1157-1166.[18] POWERS W J,RABINSTEIN A A,ACKERSONT,et al. Guidelines for the early management ofpatients with acute ischemic stroke:2019 updateto the 2018 guidelines for the early management ofacute ischemic stroke:a guideline for healthcareprofessionals from the American Heart Association/American Stroke Association[J/OL]. Stroke,2019,50(12):e344-e418[2019-12-11]. https://doi.org/10.1161/STR.0000000000000211.[19] LIN S F,CHAO A C,HU H H,et al. Hyperglycemiapredicts unfavorable outcomes in acute ischemicstroke patients treated with intravenous thrombolysisamong a Chinese population:a prospective cohortstudy[J/OL]. J Neurol Sci,2018,388:195-202[2019-12-11]. https://doi.org/10.1016/j.jns.2018.03.022.[20] OSEI E,FONVILLE S,ZANDBERGEN A,etal. Impaired fasting glucose is associated withunfavorable outcome in ischemic stroke patientstreated with intravenous alteplase[J]. J Neurol,2018,265(6):1426-1431.[21] UCHIMURA I,KAIBARA M,NAGASAWAM,et al. Effect of circulating tissue factor onhypercoagulability in type 2 diabetes mellitusstudied by rheometry and dielectric bloodcoagulometry[J]. Biorheology,2016,53(5/6):209-219.[22] CAPES S E,HUNT D,MALMBERG K,et al.Stress hyperglycemia and prognosis of stroke innondiabetic and diabetic patients:a systematicoverview[J]. Stroke,2001,32(10):2426-2432.[23] BOSHUIZEN M,STEINBERG G K. Stem Cell -based immunomodulation after stroke:effects onbrain repair processes[J]. Stroke,2018,49(6):1563-1570.[24] PEREZ-DE-PUIG I,MIRO-MUR F,FERRERFERRERM,et al. Neutrophil recruitment to thebrain in mouse and human ischemic stroke[J]. ActaNeuropathol,2015,129(2):239-257.[25] LIU H H,WANG R J,SHI J J,et al. Baselineneutrophil counts and neutrophil ratio may predicta poor clinical outcome in minor stroke patientswith intravenous thrombolysis[J/OL]. J StrokeCerebrovasc Dis,2019,28(11):104340[2019-12-11]. https://doi.org/10.1016/j.jstrokecerebrovasdis.2019.104340.[26] MAESTRINI I,STRBIAN D,GAUTIER S,etal. Higher neutrophil counts before thrombolysisfor cerebral ischemia predict worse outcomes[J].Neurology,2015,85(16):1408-1416.[27] GENSICKE H,AL SULTAN A S,STRBIAN D,etal. Intravenous thrombolysis and platelet count[J/OL].Neurology,2018,90(8):e690-e697[2019-12-11].https://doi.org/10.1212/WNL.0000000000004982.[28] KANNAN M,AHMAD F,SAXENA R. Plateletactivation markers in evaluation of thrombotic riskfactors in various clinical settings[J/OL]. BloodRev,2019,37:100583[2019-12-11]. https://doi.org/10.1016/j.blre.2019.05.007.[29] STASZEWSKI J,POGODA A,DATA K,et al.The mean platelet volume on admission predictsunfavorable stroke outcomes in patients treated withIV thrombolysis[J/OL]. Clin Interv Aging,2019,14:493-503[2019-12-11]. https://doi.org/10.2147/CIA.S195451.[30] CHEN S Y,LIN Y S,CHENG Y F,et al. Meanplatelet volume-to-lymphocyte ratio predicts poorfunctional outcomes among ischemic stroke patientstreated with intravenous thrombolysis[J/OL]. FrontNeurol,2019,10:1274[2019-12-11]. https://doi.org/10.3389/fneur.2019.01274.[31] DALKARA T,ARSAVA E M. Can restoringincomplete microcirculatory reperfusion improvestroke outcome after thrombolysis?[J]. J Cereb BloodFlow Metab,2012,32(12):2091-2099.[32] KRAUSE G S,WHITE B C,AUST S D,et al. Braincell death following ischemia and reperfusion:aproposed biochemical sequence[J]. Crit Care Med,1988,16(7):714-726.[33] SIESJO B K. Pathophysiology and treatment of focalcerebral ischemia. Part I:pathophysiology[J]. JNeurosurg,1992,77(2):169-184.[34] WANG X Y,LO E H. Triggers and mediators ofhemorrhagic transformation in cerebral ischemia[J].Mol Neurobiol,2003,28(3):229-244.[35] SUN M S,JIN H,SUN X,et al. Free radicaldamage in ischemia-reperfusion injury:an obstaclein acute ischemic stroke after revascularizationtherapy[J/OL]. Oxid Med Cell Longev,2018,2018:3804979[2019-12-11]. https://doi.org/10.1155/2018/3804979.[36] SEET R C,RABINSTEIN A A. Symptomaticintracranial hemorrhage following intravenousthrombolysis for acute ischemic stroke:a criticalreview of case definitions[J]. Cerebrovasc Dis,2012,34(2):106-114.[37] YAGHI S,WILLEY J Z,CUCCHIARA B,etal. Treatment and outcome of hemorrhagictransformation after intravenous alteplase in acuteischemic stroke:a scientific statement for healthcareprofessionals from the American Heart Association/American Stroke Association[J/OL]. Stroke,2017,48(12):e343-e361[2019-12-11]. https://doi.org/10.1161/STR.0000000000000152.[38] LEES K R,BLUHMKI E,VON KUMMER R,etal. Time to treatment with intravenous alteplaseand outcome in stroke:an updated pooled analysisof ECASS,ATLANTIS,NINDS,and EPITHETtrials[J]. Lancet,2010,375(9727):1695-1703.[39] YAGHI S,BOEHME A K,DIBU J,et al. Treatmentand outcome of thrombolysis-related hemorrhage:amulticenter retrospective study[J]. JAMA Neurol,2015,72(12):1451-1457.[40] STRBIAN D,SAIRANEN T,MERETOJA A,etal. Patient outcomes from symptomatic intracerebralhemorrhage after stroke thrombolysis[J]. Neurology,2011,77(4):341-348.[41] 王茂湘,王晓东,范铁平,等. 急性缺血性脑卒中患者静脉溶栓后出血转化与预后分析[J]. 当代医学,2018,24(21):144-145.[42] 李弘,石秋艳,张春阳,等. 血糖及血糖变异性对急性缺血性脑卒中静脉溶栓预后的影响[J]. 中华老年心脑血管病杂志,2016,18(5):518-521.[43] SHI J,PENG H,YOU S,et al. Increase inneutrophils after recombinant tissue plasminogenactivator thrombolysis predicts poor functionaloutcome of ischaemic stroke:a longitudinal study[J].Eur J Neurol,2018,25(4):645-687.[44] STRBIAN D,MICHEL P,SEIFFGE D J,et al.Symptomatic intracranial hemorrhage after strokethrombolysis:comparison of prediction scores[J].Stroke,2014,45(3):752-758.[45] SUNG S F,CHEN S C,LIN H J,et al. Comparisonof risk-scoring systems in predicting symptomatic intracerebral hemorrhage after intravenousthrombolysis[J]. Stroke,2013,44(6):1561-1566.[46] LI M,WANG-QIN R Q,WANG Y L,et al.Symptomatic intracerebral hemorrhage afterintravenous thrombolysis in Chinese patients:comparison of prediction models[J]. J StrokeCerebrovasc Dis,2015,24(6):1235-1243.[47] BARBER P A,DEMCHUK A M,ZHANGJ,et al. Validity and reliability of a quantitativecomputed tomography score in predicting outcomeof hyperacute stroke before thrombolytic therapy.ASPECTS Study Group. Alberta Stroke ProgrammeEarly CT Score[J]. Lancet,2000,355(9216):1670-1674.[48] KENT D M,SELKER H P,RUTHAZER R,et al.The stroke-thrombolytic predictive instrument:apredictive instrument for intravenous thrombolysisin acute ischemic stroke[J]. Stroke,2006,37(12):2957-2962.[49] STRBIAN D,MERETOJA A,AHLHELM F J,etal. Predicting outcome of IV thrombolysis-treatedischemic stroke patients:the DRAGON score[J].Neurology,2012,78(6):427-432.[50] SAPOSNIK G,FANG J,KAPRAL M K,et al. TheiScore predicts effectiveness of thrombolytic therapyfor acute ischemic stroke[J]. Stroke,2012,43(5):1315-1322.[51] FLINT A C,FAIGELES B S,CULLEN S P,et al.THRIVE score predicts ischemic stroke outcomesand thrombolytic hemorrhage risk in VISTA[J].Stroke,2013,44(12):3365-3369.[52] FLINT A C,CULLEN S P,FAIGELES B S,et al.Predicting long-term outcome after endovascularstroke treatment:the totaled health risks in vascularevents score[J]. AJNR Am J Neuroradiol,2010,31(7):1192-1196.[53] SEIFFGE D J,KARAGIANNIS A,STRBIAN D,etal. Simple variables predict miserable outcome afterintravenous thrombolysis[J]. Eur J Neurol,2014,21(2):185-191.[54] CAPPELLARI M,TURCATO G,FORLIVESIS,et al. The START nomogram for individualizedprediction of the probability of unfavorable outcomeafter intravenous thrombolysis for stroke[J]. Int JStroke,2018,13(7):700-706.[55] SONG B L,CHEN X L,TANG D,et al. ExternalValidation of START nomogram to predict 3-Monthunfavorable outcome in Chinese acute strokepatients[J]. J Stroke Cerebrovasc Dis,2019,28(6):1618-1622. |
[1] | LU Yan, YANG Baorong, HUANG Xiangping, YANG Guangui, CHEN Shengwen, LI Jianrong, ZENG Xiaoming. MRI-Guided Thrombolysis beyond Time Window in Acute Ischemic Stroke in a County-Level Hospital: A Case-Control Study [J]. Chinese Journal of Stroke, 2022, 17(12): 1321-1326. |
[2] | WANG Kaiwen, LU Baoquan, WU Xiuling, MA Jiali. A Novel BAOPS-MRA Score Predicts Outcome in Nonsevere Basilar Artery Occlusion [J]. Chinese Journal of Stroke, 2022, 17(12): 1335-1342. |
[3] | SONG Yanli, LIN Jie, WU Yiping, LI Xiaojing, LIU Gaifen, XIA Wenjing, ZHANG Yuying, ZHANG Xiaolin, LYU Chenran, ZHOU Hong, LI Kai, XUE Bin, CHEN Lingling, ZHANG Zhongbo, PENG Xiao. Epidemiological Survey on the Risk Factors of Cardio-Cerebrovascular Diseases among Residents in Handan and Influencing Factors of Awareness, Treatment and Control Rate of Hypertension [J]. Chinese Journal of Stroke, 2022, 17(12): 1360-1365. |
[4] | WU Yuqian, ZHANG Yumei, FAN Xiaowei, WANG Anxin, PANG Wenbin. The Efficacy of Kinesthetic Motor Imagery Therapy for Hand Function Rehabilitation of Stroke Patients [J]. Chinese Journal of Stroke, 2022, 17(12): 1366-1371. |
[5] | WU Xiaoli, LIU Lixu. The Effect of Obesity on Prognosis of Stroke [J]. Chinese Journal of Stroke, 2022, 17(12): 1391-1395. |
[6] | YI Luo, ZHOU Hongyu, QIU Xin, LI Zixiao, WANG Yongjun. DNA Methylation Changes in Atherosclerotic Diseases [J]. Chinese Journal of Stroke, 2022, 17(11): 1163-1170. |
[7] | WANG Yubo, LI Zixiao, WANG Yongjun. Progress of the Relationship between Epigenetics and Oxidative Stress after Ischemic Stroke [J]. Chinese Journal of Stroke, 2022, 17(11): 1171-1177. |
[8] | CUI Lingyun, QIU Xin, ZHOU Hongyu, LI Zixiao, WANG Yongjun. Progress of the Relationship between DNA Methylation and Type 2 Diabetes [J]. Chinese Journal of Stroke, 2022, 17(11): 1183-1188. |
[9] | DENG Yuhan, LIU Shuang, WANG Ziyao, WANG Yuxin, LIU Baohua. The Effect of Machine Learning Model for Predicting Stroke Risk in the General Population Based on Structured Data: A Systematic Review and Meta-Analysis [J]. Chinese Journal of Stroke, 2022, 17(11): 1189-1197. |
[10] | LIU Guangliang, HAN Kaiyue, SU Wenlong, ZHANG Hao. Effects of Aerobic Cycling Training Intensity on Motor and Cardiopulmonary Fitness in Patients with Ischemic Stroke [J]. Chinese Journal of Stroke, 2022, 17(11): 1203-1208. |
[11] | HU Hongmei, YANG Lei, YU Ling, QIN Wei, BAI Mingyue, HU Wenli. Clinical Features of Acute Single Small Cerebellar Infarction [J]. Chinese Journal of Stroke, 2022, 17(11): 1221-1226. |
[12] | XU Yingxin, ZHANG Shuang, ZHOU Xiaomei, YUAN Jinglin, ZHAO Liuzhuang, YANG Haihua. Correlation of Non-Stenotic Carotid Plaque with Anterior Circulation Embolic Stroke of Undetermined Source [J]. Chinese Journal of Stroke, 2022, 17(11): 1233-1237. |
[13] | CHENG Shi, LI Jing, GUO Junping, HU Aixiang, YU Xinwei, HAN Wei, LIANG Ying, ZHANG Yuewei, JI Ruijun. Clinical Characteristics and Risk Factors of Infection in Patients with Acute Stroke during Hospitalization [J]. Chinese Journal of Stroke, 2022, 17(10): 1065-1070. |
[14] | XIANG Wei, XU Luyao, ZHANG Manman, WEI Hongchun, LIANG Zhigang. The Frequency and Influencing Factors of Asymmetrical Prominent Veins Sign on Susceptibility-Weighted Imaging in Acute Ischemic Stroke [J]. Chinese Journal of Stroke, 2022, 17(10): 1097-1102. |
[15] | ZHAO Yongrui, LIU Zhanhui. Progress of Diffusion Tensor Imaging in Evaluating Motor Function Prognosis of Patients with Ischemic Stroke [J]. Chinese Journal of Stroke, 2022, 17(10): 1114-1119. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||